Cargando…
Impact of smoking status on outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
There are some data showing lower mortality of smokers comparing to non-smokers in patients with ST-segment elevation myocardial infarction (STEMI) when treated with thrombolysis or without reperfusion therapy. However, the role of smoking status is less established in patients with STEMI undergoing...
Autores principales: | Rakowski, Tomasz, Siudak, Zbigniew, Dziewierz, Artur, Dubiel, Jacek S., Dudek, Dariusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459076/ https://www.ncbi.nlm.nih.gov/pubmed/22773074 http://dx.doi.org/10.1007/s11239-012-0764-0 |
Ejemplares similares
-
Age-related differences in treatment strategies and clinical outcomes in unselected cohort of patients with ST-segment elevation myocardial infarction transferred for primary angioplasty
por: Dziewierz, Artur, et al.
Publicado: (2012) -
Early administration of abciximab reduces mortality in female patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the EUROTRANSFER Registry)
por: Dziewierz, Artur, et al.
Publicado: (2012) -
Contemporary use of P2Y(12) inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry
por: Rakowski, Tomasz, et al.
Publicado: (2017) -
Treatment Delay and Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction during the COVID-19 Pandemic
por: Tokarek, Tomasz, et al.
Publicado: (2021) -
Introduction of new oral antiplatelet drugs in myocardial infarction hospital network: initial experience
por: Rakowski, Tomasz, et al.
Publicado: (2013)